X.-L. Liu, Z.-B. Yu, B.-W. Pan, L. Chen, T.-T. Feng, and Y. Zhou
Vol 000
ppm): 0.84 (t, J = 7.1 Hz, 3H), 1.16–1.25 (m, 2H), 1.59–1.78 (m,
2H), 2.02 (s, 3H), 2.74–2.84 (m, 2H), 3.36–3.43 (m,1H), 6.92 (s,
1H), 7.20 (dd, J = 8.4, 18.1 Hz, 2H), 7.75 (s, 1H), 8.25 (br s, 1H);
13C-NMR (75 MHz, CDCl3, d, ppm): 14.0, 20.7, 30.5, 32.5, 38.1,
50.0, 112.5, 112.8, 118.6, 121.8, 122.6, 124.7, 128.3, 135.2,
208.9.
(R)-4-(2-Methyl-1H-indol-3-yl)-4-phenylbutan-2-one (5cc)
(Table 2, entry 9). The ee was determined by HPLC analysis
using a Chiralpak AD-H column (15/85 i-PrOH/hexane; flow
rate 1.0 mL/min; l = 254 nm; tminor = 7.66 min; tmajor = 8.39 min).
[a]RDT = +4.5 (c = 0.48, CHCl3, 46% ee). 1H-NMR (300 MHz,
CDCl3, d, ppm): 1.98 (s, 3H), 2.33 (s, 3H), 3.29 (dd, J = 6.2,
16.2 Hz, 1H), 3.42 (dd, J = 8.5, 16.0 Hz, 1H), 4.84 (t, J = 6.9 Hz,
1H), 6.98–7.29 (m, 8H), 7.44 (d, J = 7.5 Hz, 1H), 7.77 (br, 1H);
13C-NMR (75 MHz, CDCl3, d, ppm): 11.6, 30.3, 36.4, 47.8,
110.0, 112.7, 118.6, 118.7, 120.3, 125.5, 126.9, 127.8, 131.3,
135.0, 143.6, 207.5.
Calcd for (C21H17NOS + Na)+ requires m/z 354.1031, found m/z
354.0922.
(R)-3-(1H-Indol-3-yl)-3-phenyl-1-(thiophen-2-yl)propan-1-one
(5ah) (Table 2, entry 14).
The ee was determined by HPLC
analysis using an AD-H column (15/85 i-PrOH/hexane; flow rate
1.0 mL/min; l = 254nm; tminor =19.74 min; tmajor = 21.52 min).
[a]RDT = ꢁ20.7 (c = 0.52, CHCl3, 63% ee). 1H-NMR (300MHz,
DMSO-d6, d, ppm): 3.70 (dd, J = 7.0, 15.9 Hz, 1H), 3.86 (dd,
J = 6.9, 15.9 Hz, 1H), 4.88 (d, J = 6.5 Hz, 1H), 6.89–7.41 (m,11H),
7.94 (s, 1H), 8.11 (s, 1H), 10.86 (s, 1H); 13C-NMR (75MHz,
DMSO-d6, d, ppm): 38.0, 44.6, 111.3, 117.7, 118.3, 118.7, 121.0,
121.9, 125.9, 126.3, 127.7, 128.1, 128.6, 133.4, 134.8, 136.3,
144.3, 144.9, 191.4. HRMS (ESI) exact mass Calcd for
(C21H17NOS + Na)+ requires m/z 354.1031, found m/z 354.0919.
(S)-3-(Furan-2-yl)-3-(1H-indol-3-yl)-1-phenylpropan-1-one
(5ai) (Table 2, entry 15). The ee was determined by HPLC
analysis using an OD-H column (15/85 i-PrOH/hexane; flow rate
1.0 mL/min; l = 254 nm; tminor = 13.37 min; tmajor = 15.96 min).
[a]RDT = +8.3 (c = 0.52, CHCl3, 58% ee). 1H-NMR (300 MHz,
CDCl3, d, ppm): 3.66 (dd, J = 6.6, 16.7Hz, 1H), 3.86 (dd, J = 7.2,
16.6Hz, 1H), 5.13 (t, J = 6.6 Hz, 1H), 6.05 (s, 1H), 6.15 (s, 1H),
7.00–7.58 (m, 9H), 7.91 (d, J= 7.3 Hz, 2H), 8.01 (s, 1H); 13C-NMR
(75 MHz, CDCl3, d, ppm): 31.8, 42.7, 105.2, 109.7, 110.8, 116.2,
118.9, 119.1, 121.6, 125.8, 127.6, 128.1, 132.5, 136.1, 136.6,
140.7, 156.5, 197.8. HRMS (ESI) exact mass Calcd for
(C21H17NO2 + Na)+ requires m/z 338.1259, found m/z 338.1153.
(R)-1-(4-Chlorophenyl)-3-(1H-indol-3-yl)-3-phenylpropan-1-
one (5ad) (Table 2, entry 10). The ee was determined by HPLC
analysis using a Chiralpak AD-H column (15/85 i-PrOH/hexane;
flow rate 1.0 mL/min; l = 254 nm; tminor = 21.83 min; tmajor
=
24.65 min). [a]RDT = ꢁ28.2 (c = 0.58, CHCl3, 69% ee). 1H-NMR
(300 MHz, CDCl3, d, ppm): 3.66 (dd, J = 7.4, 16.6 Hz, 1H),
3.72–3.79 (m, 1H), 5.02 (t, J = 6.5 Hz, 1H), 6.60–7.43 (m,
12H), 7.80–7.89 (m, 2H), 7.94 (s, 1H); 13C-NMR (75 MHz,
CDCl3, d, ppm): 38.4, 45.2, 111.0, 111.2, 119.1, 119.2,
119.5, 121.4, 121.9, 122.2, 123.4, 126.4, 126.6, 127.8, 128.2,
128.5, 128.9, 129.5, 135.5, 136.7, 139.5, 144.0, 197.5. HRMS
(ESI) exact mass Calcd for (C23H18ClNO + Na)+ requires m/z
382.1077, found m/z 382.0965.
Acknowledgments. We are grateful for financial support from the
National Natural Science Foundation of China (No. 21062003)
and Modernization of Traditional Chinese Medicine special of
Guiyang ([2010] Zhu Ke Hetongzi 1-Zhong-18).
(R)-3-(1H-Indol-3-yl)-1-(3-methoxyphenyl)-3-phenylpropan-
1-one (5ae) (Table 2, entry 11). The ee was determined by HPLC
analysis using an OD-H column (30/70 i-PrOH/hexane; flow rate
1.0 mL/min; l = 254nm;
tminor = 10.7min; tmajor = 17.78 min).
[a]RDT = ꢁ24.0 (c = 0.65, CHCl3, 63% ee). 1H-NMR (300 MHz,
CDCl3, d, ppm): 3.67–3.74 (m, 2H), 3.83 (s, 3H), 5.05 (s, 1H),
6.87–7.43 (m, 12H), 7.91 (d, J = 7.2 Hz, 2H), 7.96 (bs, 1H); 13C-
NMR (75 MHz, CDCl3, d, ppm): 38.0, 44.4, 54.9, 110.6, 113.2,
118.9, 119.1, 121.0, 121.6, 125.7, 126.2, 127.4, 127.9, 129.9,
136.2, 143.9, 162.9, 196.6.
REFERENCES
[1] (a) Seayad, J.; List, B. Org Biomol Chem 2005, 3, 719; (b)
Dalko, P. I.; Moisan, L. Angew Chem Int Ed 2004, 43, 5138.
[2] (a) Akiyama, T.; Itoh, J.; Yoko, K.; Fuchibe, K. Angew Chem
Int Ed 2004, 43, 1566; (b) Uraguchi, D.; Terada, M. J. Am Chem Soc
2004, 126, 5356.
[3] For recent reviews on phosphoric acid catalysis, see (a)
Connon, S. J. Angew Chem Int Ed 2006, 45, 3909; (b) Akiyama, T. Chem
Rev 2007, 107, 5744; (c) Terada, M. Synthesis 2010, 1929; (d) Zamfir,
A.; Schenker, S.; Freund, M.; Esogoeva, S. B. Org Biomol Chem 2010,
8, 5262; (e) Yu, J.; Shi, F.; Gong, L.-Z. Accounts of Chemical Research
2011, 44, 1156 and references cited therein.
[4] (a) Aubry, C.; Patel, A.; Mahale, S.; Chaudhuri, B.; Sutclie, M.
J.; Jenkins, P. R. Tetrahedron Lett 2005, 46, 1423; (b) Austin, J. F.;
MacMillan, D. W. C. J Am Chem Soc 2002, 124, 1172.
[5] (a) Zhang, H.-C.; Ye, H.; Moretto, A. F.; Brumeld, K. K.;
Maryano, B. E. Org Lett 2000, 2, 89; (b) Faul, M. M.; Winneroski,
L. L.; Krumrich, C. A. J Org Chem 1998, 63, 6053; (c) Bennasar, M.
L.; Vidal, B.; Bosch, J. J Org Chem 1997, 62, 3597.
[6] Gribble, G. W. J Chem Soc, Perkin Trans 1 2000, 1045.
[7] (a) Szmuszkovicz, J. J Am Chem Soc 1975, 79, 2819; (b)
Noland, W. E.; Christensen, G. M.; Sauer, G. L.; Dutton, G. G. S. J Am
Chem Soc 1955, 77, 456; (c) Iqbal, Z.; Jackson, A. H.; Rao, K. R. N.
Tetrahedron Lett 1988, 29, 2577.
[8] (a) Harrington, P. E.; Kerr, M. A. Synlett 1996, 11, 1047; (b)
Harrington, P.; Kerr, M. A. Can J Chem 1998, 76, 1256; (c) Loh, T. P.;
Wei, L. L. Synlett 1998, 4, 975; (d) Loh, T. P.; Pei, J.; Lin, M. Chem Com-
mun 1996, 20, 2315; (e) Yadav, J. S.; Abraham, S.; Reddy, B. V. S.;
Sabitha, G. Synthesis 2001, 14, 2165; (f) Bandini, M.; Cozzi, P. G.; Giaco-
mini, M.; Melchiorre, P.; Selva, S.; Umani-Ronchi, A. J Org Chem 2002,
(R)-3-(1H-Indol-3-yl)-3-(naphthalen-2-yl)-1-phenylpropan-1-
one (5af) (Table 2, entry 12). The ee was determined by HPLC
analysis using an OD-H column (15/85 i-PrOH/hexane; flow rate
1.0 mL/min; l = 254 nm; tminor = 22.10 min; tmajor = 25.37 min).
[a]RDT = ꢁ5.7 (c = 0.56, CHCl3, 68% ee). 1H-NMR (300 MHz,
CDCl3, d, ppm): 3.79–3.90 (m, 2H), 5.23 (t, J = 6.9 Hz, 1H), 6.62
(s, 2H), 6.94–7.51 (9H), 7.70–7.78 (m, 4H), 7.92 (d, J = 7.7 Hz,
3H). 13C-NMR (75 MHz, CDCl3, d, ppm): 38.4, 45.1, 111.1,
111.2, 119.2, 119.5, 119.6, 121.6, 122.2, 125.4, 125.9, 126.0,
126.7, 127.6, 127.8, 128.1, 128.6, 132.3, 133.0, 133.5, 136.7,
137.2, 141.7, 198.5. HRMS (ESI) exact mass Calcd for
(C27H21NO + Na)+ requires m/z 398.1623, found m/z 398.1519.
(S)-3-(1H-Indol-3-yl)-1-phenyl-3-(thiophen-2-yl)propan-1-one
(5ag) (Table 2, entry 13).
The ee was determined by HPLC
analysis using an AD-H column (15/85 i-PrOH/hexane; flow rate
1.0 mL/min; l = 254 nm; tminor = 18.49min; tmajor = 20.97 min).
[a]RDT = ꢁ6.5 (c = 0.74, CHCl3, 59% ee). 1H-NMR (300 MHz,
CDCl3, d, ppm): 3.80 (d, J = 6.7 Hz, 2H), 5.35 (t, J = 6.6 Hz, 1H),
6.84–7.54 (m, 11H), 7.90 (d, J = 7.3 Hz, 2H), 7.99 (s, 1H); 13C-
NMR (75MHz, CDCl3, d, ppm): 33.1, 45.7, 110.8, 118.5, 119.0,
119.1, 121.2, 121.7, 123.0, 123. 8, 125.8, 126.1, 127.7, 128.1,
132.6, 136.1, 136.6, 148.3, 197.7. HRMS (ESI) exact mass
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet